RNAi Technology Market Research Reports

"...... sion analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types. In the report, we only collect information about the companies who ......"

"...... USD 6014.66 million in 2028, with a CAGR of 6.12% during the forecast years. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest. It offers both quantitative and qu......"

"...... ada market for RNA In Situ Hybridization is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for RNA In Situ Hybridization is esti......"

"...... The US & Canada market for Antisense and RNAi Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Antisense and RNAi The......"

"...... e global market of miRNA tools and provides an updated review including its applications in various arenas of diagnostics and therapeutics. The report deals with miRNA tools covering technologies used in the biomedical industry. These products are mi......"

"...... erna Pharmaceuticals, Mirna Therapeutics, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for RNAi for Therapeutic fr......"

"...... , and consumption area of miRNA. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies. In Chapter 2.3 of the report, the impact of the COV......"

"...... , and breaks down according to the type, application, and consumption area of Antisense and RNAi Therapeutics. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading......"

"...... apeutics has moved very quickly from lab to bedside. The RNAi approach has been widely used for drug development and several phase I and II clinical trials are under way. However, there are still some concerns and challenges to overcome for therapeut......"

"...... observed. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. T......"